The effects of calorie-matched high-fat diet consumption on spontaneous physical activity and development of obesity

Life Sciences

Volumn 179, Issue , 2017, Pages 30-36

  Moretto, Thais Ludmilla ^a   Benfato, Izabelle Dias ^a   de Carvalho, Francine Pereira ^a   Barthichoto, Marcela ^a   Le Sueur Maluf, Luciana ^a   de Oliveira, Camila Aparecida Machado ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Energy homeostasis; High fat diet; Hypothalamus; Obesity; Spontaneous physical activity

Indexed keywords

ADRENERGIC RECEPTOR ALPHA 2B; AGOUTI RELATED PROTEIN; BRAIN DERIVED NEUROTROPHIC FACTOR; GLUCOSE; INSULIN; INTERLEUKIN 6; PEPTIDE YY; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; GLUCOSE BLOOD LEVEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CALORIC INTAKE; CONTROLLED STUDY; DIET INDUCED OBESITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FAT PAD; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HYPOTHALAMUS; INSULIN BLOOD LEVEL; LIPID DIET; MALE; MOUSE; NONHUMAN; PHYSICAL ACTIVITY; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; ANIMAL; C57BL MOUSE; ENERGY METABOLISM; GENE EXPRESSION REGULATION; METABOLISM; OBESITY; PHYSIOLOGY; WEIGHT GAIN;

ADIPOSITY; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; DIET, HIGH-FAT; ENERGY INTAKE; ENERGY METABOLISM; GENE EXPRESSION REGULATION; HYPOTHALAMUS; INTERLEUKIN-6; MALE; MICE; MICE, INBRED C57BL; OBESITY; PHYSICAL CONDITIONING, ANIMAL; REAL-TIME POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA; WEIGHT GAIN;

EID: 85018405078     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2017.04.017     Document Type: Article

References (59)

1. [1] Hallal, P.C., et al. Global physical activity levels: surveillance progress, pitfalls, and prospects. Lancet 380:9838 (2012), 247–257.
2. [2] Booth, F.W., et al. Waging war on modern chronic diseases: primary prevention through exercise biology. J. Appl. Physiol. 88:2 (1985), 774–787 2000.
3. [3] Booth, F.W., Chakravarthy, M.V., Spangenburg, E.E., Exercise and gene expression: physiological regulation of the human genome through physical activity. J. Physiol. 543:Pt 2 (2002), 399–411.
4. [4] Chakravarthy, M.V., Booth, F.W., Eating, exercise, and “thrifty” genotypes: connecting the dots toward an evolutionary understanding of modern chronic diseases. J. Appl. Physiol. 96:1 (1985), 3–10 2004.
5. [5] Lee, I.M., et al. Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy. Lancet 380:9838 (2012), 219–229.
6. [6] WHO, World Health Organization - Obesity and Overweight. 2008 (Available from: http://www.who.int/mediacentre/factsheets/fs311/en/).
7. [7] Levine, J.A., Nonexercise activity thermogenesis (NEAT): environment and biology. Am. J. Physiol. Endocrinol. Metab. 286:5 (2004), E675–E685.
8. [8] Garland, T., et al. The biological control of voluntary exercise, spontaneous physical activity and daily energy expenditure in relation to obesity: human and rodent perspectives. J. Exp. Biol. 214:Pt 2 (2011), 206–229.
9. [9] Levine, J.A., et al. Interindividual variation in posture allocation: possible role in human obesity. Science 307:5709 (2005), 584–586.
10. [10] Levine, J.A., Eberhardt, N.L., Jensen, M.D., Role of nonexercise activity thermogenesis in resistance to fat gain in humans. Science 283:5399 (1999), 212–214.
11. [11] Levine, J.A., et al. Non-exercise activity thermogenesis: the crouching tiger hidden dragon of societal weight gain. Arterioscler. Thromb. Vasc. Biol. 26:4 (2006), 729–736.
12. [12] Novak, C.M., Levine, J.A., Central neural and endocrine mechanisms of non-exercise activity thermogenesis and their potential impact on obesity. J. Neuroendocrinol. 19:12 (2007), 923–940.
13. [13] Moore-Harrison, T., Lightfoot, J.T., Driven to be inactive? The genetics of physical activity. Prog. Mol. Biol. Transl. Sci. 94 (2010), 271–290.
14. [14] Bjursell, M., et al. Acutely reduced locomotor activity is a major contributor to western diet-induced obesity in mice. Am. J. Physiol. Endocrinol. Metab. 294:2 (2008), E251–E260.
15. [15] Funkat, A., et al. Metabolic adaptations of three inbred strains of mice (C57BL/6, DBA/2, and 129T2) in response to a high-fat diet. J. Nutr. 134:12 (2004), 3264–3269.
16. [16] Novak, C.M., et al. Caloric restriction and physical activity in zebrafish (Danio rerio). Neurosci. Lett. 383:1–2 (2005), 99–104.
17. [17] Thaler, J.P., et al. Obesity is associated with hypothalamic injury in rodents and humans. J. Clin. Invest. 122:1 (2012), 153–162.
18. [18] Hennige, A.M., et al. Insulin-mediated cortical activity in the slow frequency range is diminished in obese mice and promotes physical inactivity. Diabetologia 52:11 (2009), 2416–2424.
19. [19] De Souza, C.T., et al. Consumption of a fat-rich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus. Endocrinology 146:10 (2005), 4192–4199.
20. [20] Shoelson, S.E., Lee, J., Goldfine, A.B., Inflammation and insulin resistance. J. Clin. Invest. 116:7 (2006), 1793–1801.
21. [21] Velloso, L.A., The brain is the conductor: diet-induced inflammation overlapping physiological control of body mass and metabolism. Arq. Bras. Endocrinol. Metabol. 53:2 (2009), 151–158.
22. [22] Naert, G., et al. Continuous i.c.v. infusion of brain-derived neurotrophic factor modifies hypothalamic-pituitary-adrenal axis activity, locomotor activity and body temperature rhythms in adult male rats. Neuroscience 139:2 (2006), 779–789.
23. [23] An, J.J., et al. Discrete BDNF neurons in the paraventricular hypothalamus control feeding and energy expenditure. Cell Metab. 22:1 (2015), 175–188.
24. [24] Noble, E.E., et al. The lighter side of BDNF. Am. J. Phys. Regul. Integr. Comp. Phys., 300(5), 2011 R1053-69.
25. [25] Astrup, A., et al. Nutrition transition and its relationship to the development of obesity and related chronic diseases. Obes. Rev. 9:Suppl. 1 (2008), 48–52.
26. [26] Williams, L.M., et al. The development of diet-induced obesity and glucose intolerance in C57BL/6 mice on a high-fat diet consists of distinct phases. PLoS One, 9(8), 2014, e106159.
27. [27] Reeves, P.G., Nielsen, F.H., Fahey, G.C., AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J. Nutr. 123:11 (1993), 1939–1951.
28. [28] Kotz, C.M., Integration of feeding and spontaneous physical activity: role for orexin. Physiol. Behav. 88:3 (2006), 294–301.
29. [29] Kotz, C.M., et al. Orexin a mediation of time spent moving in rats: neural mechanisms. Neuroscience 142:1 (2006), 29–36.
30. [30] Levine, J.A., Schleusner, S.J., Jensen, M.D., Energy expenditure of nonexercise activity. Am. J. Clin. Nutr. 72:6 (2000), 1451–1454.
31. [31] Agurs-Collins, T., Bouchard, C., Gene-nutrition and gene-physical activity interactions in the etiology of obesity. Introduction. Obesity (Silver Spring) 16:Suppl. 3 (2008), S2–S4.
32. [32] Jais, A., Brüning, J.C., Hypothalamic inflammation in obesity and metabolic disease. J. Clin. Invest. 127:1 (2017), 24–32.
33. [33] Dalvi, P.S., et al. High fat induces acute and chronic inflammation in the hypothalamus: effect of high-fat diet, palmitate and TNF-α on appetite-regulating NPY neurons. Int. J. Obes. 41:1 (2017), 149–158.
34. [34] Skelly, D.T., et al. A systematic analysis of the peripheral and CNS effects of systemic LPS, IL-1β, [corrected] TNF-α and IL-6 challenges in C57BL/6 mice. PLoS One, 8(7), 2013, e69123.
35. [35] Senn, J.J., et al. Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes 51:12 (2002), 3391–3399.
36. [36] Hotamisligil, G.S., Shargill, N.S., Spiegelman, B.M., Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259:5091 (1993), 87–91.
37. [37] Hagan, M.M., et al. Opioid receptor involvement in the effect of AgRP- (83-132) on food intake and food selection. Am. J. Phys. Regul. Integr. Comp. Phys. 280:3 (2001), R814–R821.
38. [38] Barnes, M.J., Argyropoulos, G., Bray, G.A., Preference for a high fat diet, but not hyperphagia following activation of mu opioid receptors is blocked in AgRP knockout mice. Brain Res. 1317 (2010), 100–107.
39. [39] Pfluger, P.T., et al. Ghrelin, peptide YY and their hypothalamic targets differentially regulate spontaneous physical activity. Physiol. Behav. 105:1 (2011), 52–61.
40. [40] Tang-Christensen, M., et al. Central administration of ghrelin and agouti-related protein (83-132) increases food intake and decreases spontaneous locomotor activity in rats. Endocrinology 145:10 (2004), 4645–4652.
41. [41] Boules, M., et al. A novel neurotensin peptide analog given extracranially decreases food intake and weight in rodents. Brain Res. 865:1 (2000), 35–44.
42. [42] Kim, E.R., Leckstrom, A., Mizuno, T.M., Impaired anorectic effect of leptin in neurotensin receptor 1-deficient mice. Behav. Brain Res. 194:1 (2008), 66–71.
43. [43] Levine, A.S., et al. Effect of centrally administered neurotensin on multiple feeding paradigms. Pharmacol. Biochem. Behav. 18:1 (1983), 19–23.
44. [44] Williams, G., et al. Reduced hypothalamic neurotensin concentrations in the genetically obese diabetic (ob/ob) mouse: possible relationship to obesity. Metabolism 40:10 (1991), 1112–1116.
45. [45] Cador, M., et al. Behavioral analysis of the effect of neurotensin injected into the ventral mesencephalon on investigatory and spontaneous motor behavior in the rat. Psychopharmacology 85:2 (1985), 187–196.
46. [46] Elliot, D.L., et al. Metabolic evaluation of obese and nonobese siblings. J. Pediatr. 114:6 (1989), 957–962.
47. [47] Kalivas, P.W., Nemeroff, C.B., Prange, A.J., Neuroanatomical site specific modulation of spontaneous motor activity by neurotensin. Eur. J. Pharmacol. 78:4 (1982), 471–474.
48. [48] Kalivas, P.W., Nemeroff, C.B., Prange, A.J., Neurotensin microinjection into the nucleus accumbens antagonizes dopamine-induced increase in locomotion and rearing. Neuroscience 11:4 (1984), 919–930.
49. [49] Opland, D., et al. Loss of neurotensin receptor-1 disrupts the control of the mesolimbic dopamine system by leptin and promotes hedonic feeding and obesity. Mol. Metab. 2:4 (2013), 423–434.
50. [50] Vadnie, C.A., et al. Activation of neurotensin receptor type 1 attenuates locomotor activity. Neuropharmacology 85 (2014), 482–492.
51. [51] Edelsbrunner, M.E., Herzog, H., Holzer, P., Evidence from knockout mice that peptide YY and neuropeptide Y enforce murine locomotion, exploration and ingestive behaviour in a circadian cycle- and gender-dependent manner. Behav. Brain Res. 203:1 (2009), 97–107.
52. [52] Reidelberger, R.D., et al. Effects of different intermittent peptide YY (3-36) dosing strategies on food intake, body weight, and adiposity in diet-induced obese rats. Am. J. Phys. Regul. Integr. Comp. Phys. 295:2 (2008), R449–R458.
53. [53] Otterness, I.G., et al. Effects of continuously administered murine interleukin-1 alpha: tolerance development and granuloma formation. Infect. Immun. 57:9 (1989), 2742–2750.
54. [54] Bianchi, M., et al. Central effects of tumor necrosis factor alpha and interleukin-1 alpha on nociceptive thresholds and spontaneous locomotor activity. Neurosci. Lett. 148:1–2 (1992), 76–80.
55. [55] Otterness, I.G., et al. Role of prostaglandins in the behavioral changes induced by murine interleukin 1 alpha in the rat. Cytokine 3:4 (1991), 333–338.
56. [56] Binder, D.K., Scharfman, H.E., Brain-derived neurotrophic factor. Growth Factors 22:3 (2004), 123–131.
57. [57] Marosi, K., Mattson, M.P., BDNF mediates adaptive brain and body responses to energetic challenges. Trends Endocrinol. Metab. 25:2 (2014), 89–98.
58. [58] Liao, G.Y., et al. Dendritically targeted Bdnf mRNA is essential for energy balance and response to leptin. Nat. Med. 18:4 (2012), 564–571.
59. [59] Unger, T.J., et al. Selective deletion of Bdnf in the ventromedial and dorsomedial hypothalamus of adult mice results in hyperphagic behavior and obesity. J. Neurosci. 27:52 (2007), 14265–14274.